WebMar 20, 2024 · CTI develops novel therapies for patients with rare blood-related cancers by uncovering the underlying scientific drivers of their disease. Learn More Approved in the U.S. for adults with myelofibrosis … WebMay 30, 2014 · May 30, 2014, 01:30 ET. SEATTLE, May 30, 2014 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI or the Company) (NASDAQ and MTA: CTIC), a …
CTI BioPharma to Participate in Two Upcoming Investor …
WebApr 10, 2024 · CTI BioPharma Corp. CTI BioPharma is a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies … WebApr 10, 2024 · The equity awards were approved on April 10, 2024, in accordance with Nasdaq Listing Rule 5635 (c) (4). The employees received options to purchase an aggregate of 36,000 shares of CTI BioPharma ... bowlers convention centre manchester
CTI BioPharma (CTIC) Price To Cash Flow - Zacks.com
WebApr 6, 2024 · CTI BioPharma last announced its earnings data on March 6th, 2024. The biopharmaceutical company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by $0.04. The firm had revenue of $21.08 million for the quarter, compared to the consensus estimate of $24.88 million. WebAbout us. We are on a mission to make a meaningful impact on the lives of patients with blood-related cancers. At CTI, we are resolute in our commitment to deliver new … WebApr 10, 2024 · The equity awards were approved on April 10, 2024 , in accordance with Nasdaq Listing Rule 5635 (c) (4). The employees received options to purchase an aggregate of 36,000 shares of CTI BioPharma common stock. The options will be issued upon each employee's grant date (the "Grant Date"), and all stock options included within … bowlers crying towel